- analysis of data from first Phase III clinical trial nearing completion -
BELLEVILLE, ON, Aug. 19 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin(TM).
Bioniche and its development partner, Endo Pharmaceuticals Inc. (NASDAQ: ENDP), are in the process...
Bladder cancer invasive into the pelvic side wall or into adjacent organs other than the prostate, vagina, and uterus is classified as clinical stage T4b. Locally advanced tumors of this category are generally considered unresectable and patients are treated primarily with multiagent chemotherapy. This treatment is generally considered to be palliative.
Our study highlights that a subpopulation of these patients will become amenable...
TRPV2 Activation Induces Apoptotic Cell Death In Human T24 Bladder Cancer Cells: A Potential Therapeutic Target For Bladder Cancer
Article Date: 11 Aug 2010 - 0:00 PDT
Bladder carcinoma is the second most common malignancy of the urinary tract and nearly 90% of all primary tumors of the bladder are urothelial carcinomas (UCs). Superficial UCs can be "shaved off" using an electrocautery device attached to a cystoscope. Immunotherapy in the form of bacillus Calmette-Guerrin...
Gene Expression Signature In Urine For Diagnosing And Assessing Aggressiveness Of Bladder Urothelial Carcinoma
Article Date: 02 Aug 2010 - 8:00 PDT
The current diagnostic systems of bladder cancer are based upon a combination of urine cytology and direct observation of the bladder by cystoscopy. The latter is, in actual fact, the main diagnostic and tumour follow-up technique. It is performed transurethrally, and consequently it is an invasive approach, quite uncomfortable...
People with highest levels of dietary nitrite had nearly a 30 percent increase in risk, study shows
WEDNESDAY, July 28 (HealthDay News) -- Certain compounds used in meat processing may increase the risk of bladder cancer, a new study from the National Institutes of Health and the AARP shows.
U.S. researchers analyzed data from about 300,000 men and women,...